ºÚÁÏÍø

Biography

Director of the BioSpectroscopy Core Research Laboratory at Faculty of Chemistry, California South University (CSU), Irvine, California, USA President of American International Standards Institute (AISI) Irvine, California, USA

Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University.

Work Experience

2012 – Present: o President of American International Standards Institute (AISI), Irvine, California, USA. 2015 – Present: o Board of Directors Member at Pishtaz Lian Chemi Company, Qazvin, Iran.

Research Interest

Biophysical Chemistry  Biomolecular Spectroscopy  Quantum Chemistry  Nanochemistry  Modern Electronic Structure Computations  Theoretical Chemistry  Mathematical Chemistry  Computational Chemistry  Vibrational Spectroscopy  Molecular Modelling  Ab initio & Density Functional Methods  Molecular Structure  Biochemistry  Molecular Simulation  Pharmaceutical Chemistry  Medicinal Chemistry  Oncology  Synchrotron Radiation  LASER  Anti–Cancer Nano Drugs  Nano Drugs Delivery  ATR–FTIR Spectroscopy  Raman Spectroscopy  Intelligent Molecules  Molecular Dynamics  Biosensors  Biomarkers  Molecular Diagnostics  Numerical Chemistry  Nucleic Acids  DNA/RNA Monitoring 25  DNA/RNA Hypermethylation  Human Cancer Tissues  Human Cancer Cells  Tumors  Cancer Tissues  Cancer Cells

Publications

Molecular Diagnosis of Cancers Helpful Treatments

A Brief Overview on Bio Polymer Based Nano composites

The Pros and Cons of Scintimammography in the Diagnosis of Breast Cancer

Complementary and Alternative Medicines and Therapies for Cancer Prevention

Changing Metal Powder Characteristics for Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM) Proteins Adjustment in Cancer Metastases Induced by Osteosarcoma, Chondrosarcoma, Carcinoid, Carcinoma, Ewing’s Sarcoma, Fibrosarcoma and Secondary Hematopoietic Solid or Soft Tissue Tumors

Clinical Trials of Dendritic Cell Therapies for Cancer Exposing Vulnerabilities in Human Cancer Cells’ Metabolism and Metabolomics: New Discoveries, Unique Features Inform New Therapeutic Opportunities, Biotech's Bumpy Road to the Market and Elucidating the Biochemical Programs that Support Cancer Initiation and Progression